GENELUX Corp

GNLX · XNAS

CIK 1231457fmd_0T40HWR377EXFG9N6PW0PXZ0P6Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2022 to Jun 30, 2026, 18 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.